Andrew Lupo, Jr

Title: Andrew Lupo, Jr.: Innovator in Neurokinin Antagonists

Introduction

Andrew Lupo, Jr. is a notable inventor based in Emerson, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of neurokinin antagonists. With a total of 3 patents to his name, Lupo's work has the potential to impact various therapeutic areas.

Latest Patents

Lupo's latest patents include innovative compounds such as substituted oximes, hydrazones, and olefins as neurokinin antagonists. These compounds are represented by specific structural formulas, which indicate their potential as pharmaceutically acceptable salts. His research focuses on the structural variations that can enhance the efficacy of these compounds in medical applications.

Career Highlights

Andrew Lupo, Jr. is currently associated with Schering Corporation, where he continues to advance his research in pharmacology. His work at the company has allowed him to explore new avenues in drug development, particularly in the realm of neurokinin antagonists.

Collaborations

Throughout his career, Lupo has collaborated with esteemed colleagues such as Robert G. Aslanian and John J. Piwinski. These collaborations have fostered a productive environment for innovation and have contributed to the success of their joint research efforts.

Conclusion

Andrew Lupo, Jr. stands out as a dedicated inventor in the pharmaceutical industry, with a focus on neurokinin antagonists. His contributions through patents and collaborations highlight his commitment to advancing medical science.